BOTANISOL ANALYTICS, INC.

Phoenix, AZ · Medtech · Private

Field-deployable molecular diagnostic test kit for COVID-19 detection without refrigeration

botanisolanalytics.com →
Grants
$3.5M
3 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
3
0 granted · 3 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Defense · Phase I · Real Time Acquisition Of Chemical Threat Materials At Close Proximal Ranges$49,996
Federal grantDepartment of Defense · Phase II · Validating a new Hydrogen Lyman-Alpha Line (HLA) spectrometer as an instant diagnostic and threat detection system.$1,499,495
Federal grantDepartment of Defense · Phase II · Diagnostics Development and Novel Technology Development and Evaluation to Improve Diagnostic Testing Capabilities for COVID-19 Detection$1,990,393
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2240EICOM USA——
2241NEWHAPTICS CORP.——
2242Control One LLC——
2243BOTANISOL ANALYTICS, INC.——
2244SONATA LLC——
2245HOW MANY ENGINEERS INC——
2246Bionic Sciences, Inc.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 3
  • Painted Substrate For Spectroscopyapplication
  • Painted Substrate For Spectroscopyapplication
  • Painted Substrate For Spectroscopyapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.